NCT02411500View on ClinicalTrials.gov

A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Healthy
Interventions
DRUG

TRV734

Subjects will be randomized to receive the oral TRV734 treatments on Days 1, 3, 5 and 7 in an open-label, 4-period, cross-over fashion. Days 2, 4, 6 and 8 are designated as washout days.

Trial Locations (1)

78209

San Antonio

All Listed Sponsors
lead

Trevena Inc.

INDUSTRY

NCT02411500 - A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males | Biotech Hunter | Biotech Hunter